Tenaya Therapeutics, Inc. Common Stock (TNYA) is a publicly traded Healthcare sector company. As of May 21, 2026, TNYA trades at $0.81 with a market cap of $169.91M and a P/E ratio of -1.74. TNYA moved +2.73% today. Year to date, TNYA is +10.94%; over the trailing twelve months it is +69.73%. Its 52-week range spans $0.36 to $4.01. Analyst consensus is strong buy with an average price target of $12.00. Rallies surfaces TNYA's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Tenaya Therapeutics, Inc. Common Stock (TNYA) research on Rallies includes live charts, financials, analyst ratings, hedge fund holdings, politician trades, insider activity, news, AI research, and community context. TNYA moved +2.73% today. Analyst consensus is strong buy.
| Metric | Value |
|---|---|
| Price | $0.81 |
| Market Cap | $169.91M |
| P/E Ratio | -1.74 |
| EPS | $-0.46 |
| Dividend Yield | 0.00% |
| 52-Week High | $4.01 |
| 52-Week Low | $0.36 |
| Volume | 15.65K |
| Avg Volume | 0 |
| Revenue (TTM) | $225.00K |
| Net Income | $-83.00M |
| Gross Margin | 0.00% |
6 analysts cover TNYA: 0 strong buy, 6 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $12.00.